Interesting interview in Forbes with the head of WHO in India. She comes out clearly in favour of compulsory licensing- ” We welcome India’s move. It is also a good message to the industry that the India government is now mature enough to consider all the options it has and apply them as appropriate for the needs of its people.”
You are here: / / Compulsory licencing of Bayer’s cancer drug is a triumph
This site uses Akismet to reduce spam. Learn how your comment data is processed.